Skip to content
Signal Bureau What’s happening · what the record shows

Colorectal Cancer

Cancer of the colon or rectum — among the most common cancers worldwide and a major focus of screening and drug development.

Coverage of Colorectal Cancer is holding steady : 58 signals on the latest tracked day, down 21% from its three-week baseline of 73, across 3 domains (unchanged from a week ago). That makes it the #12 most-covered of the 274 concerns we track.

Colorectal Cancer is steady by its own history. Its normal rhythm is about 73 signals a day across 3 domains (19 tracked days). A real move would be a day at 91+ signals — 25% above that baseline, the bar our trend read calls accelerating — or a spread into domains beyond its usual 3. That is the move that would push it up the Wire. It sits on our Health & Bio Desk.

What’s changed

What the reporting says

It shows up alongside Immunotherapy (196), ctDNA (100), KRAS (94), MSI-H (54), Egfr (39), AI (57), Folfox (14), FDA (37).

Two steps out: Amazon (through AI, 57 shared stories on the weaker link); Anthropic (through AI, 57 shared stories on the weaker link); China (through AI, 57 shared stories on the weaker link); European Union (through AI, 57 shared stories on the weaker link).

Tracked since Oct 30, with coverage on 153 separate days — concentrated in Pubmed Targeted and Oncology.

Ask the engine about Colorectal Cancer + Track Colorectal Cancer for a daily read
Counts computed from our committed signal record (Jun 24 – Aug 8, 19 tracked days). Informational only — not financial, legal, or investment advice. Prediction-market prices are shown as a signal of what the crowd believes. Terms · Privacy · page rendered Aug 8, 7:13 PM PT